Abstract Library

#4251 Upfront Oxaliplatin–Fluoropyrimidine chemotherapy and Somatostatin Analogues (SSA) in advanced well-differentiated G2/G3 gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs)

Introduction: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are frequently diagnosed at advanced stage. For well-differentiated somatostatin receptor-positive (SSTR +) NETs, somatostatin analogues (SSAs) are the preferred first-line therapy. However, in patients (pts) with G2/G3 and a high tumor burden, SSA alone might not be enough.

Conference:

Presenting Author:

Authors: Maratta M, Sparagna I, d'Agostino F, Occhipinti D, Raia S,

Keywords: gastroenteropancreatic NET, neuroendocrine tumor, chemotherapy, conversion surgery, neoadjuvant treatment,

#4235 Tricuspid valve replacement and liver transplantation in a 51-year-old female patient with grade 1 ileum NET and refractory carcinoid syndrome

Introduction: Refractory carcinoid syndrome (RCSy) could lead to severe complications.

Conference:

Presenting Author: Tőke J

Authors: Tőke J, Kövesdi A, Szolnoky J, Huszty G, Piros L,

Keywords: refractory carcinoid syndrome, liver transplantation, ileum neuroendocrine tumor,

#4038 Identification of gastroenteropancreatic neuroendocrine tumor with high liver tumor burden based on clinicopathological features

Introduction: Liver tumor burden (LTB) is a key prognostic factor affecting survival and treatment response of GEP-NET patients. Currently available quantitative assessment of LTB relies on 68Ga-SSA PET/CT scan which is not accessible in some centers.

Conference:

Presenting Author: Chen L

Authors: Jumai N, Chen L, He Q, Liu M, Wen W,

Keywords: liver tumor burden, prediction, neuroendocrine tumor,

#3977 Serum b-HCG as a biomarker in neuroendocrine tumors: A reconsideration of single-analyte approach

Introduction: Despite recent advances, neuroendocrine tumors (NETs) remain a challenging topic due to their diverse characteristics and the lack of suitable biomarkers. The shift to an omics-based approach and the utilization of statistical algorithms present an improvement over the traditional single-analyte strategy, albeit with its own drawbacks.

Conference:

Presenting Author: Komarnicki P

Authors: Komarnicki P, Gut P, Musiałkiewicz J, Maciejewski A, Cieślewicz M,

Keywords: pancreatic neoplasms, neuroendocrine tumor, biomarker, chorionic gonadotropin, hcg-beta,

#3950 Liver debulking surgery affect the treatment efficacy of SSAs

Introduction: Since the results of the previous study, liver metastasis tumor burden affect the treatment effect of somatostatin analogues (SSAs).

Conference:

Presenting Author: Liang Y

Authors: Liang Y, Zhou J, Chen J,

Keywords: Liver metastasis, debulking surgery, SSAs,